Stay updated on Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows a new revision tag, v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T00:39:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Deleted the topic tags 'Lung cancer' and 'MedlinePlus Genetics' from the study's related topics.
    Difference
    0.1%
    Check dated 2026-02-25T18:36:56.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Lung cancer and related topics, including MedlinePlus Genetics, and updated the page revision to v3.4.2. Removed the government funding lapse notice and the previous revision v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:57:41.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and updated the page revision to v3.4.1; the previous revision v3.4.0 was removed.
    Difference
    0.2%
    Check dated 2026-02-04T06:43:18.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed core topic labels like 'Lung cancer' and related topics, affecting the trial's disease focus and discoverability. Added UI elements such as 'Show glossary' and QC-related metadata like 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T04:48:21.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Added 'Lung cancer' as a related topic and a MedlinePlus Genetics link under Related Topics. These additions improve discoverability without altering study details or results.
    Difference
    0.1%
    Check dated 2026-01-21T04:44:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic NSCLC Clinical Trial page.